Eric Shoup, PA
Physician Assistant · Columbia, SCNPI 1073576781
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,919 of the $73,689 with a category attached, or 62.3%. Amgen accounts for 64.1% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2021 at $23,259 and has fallen 68.4% since, to $7,360 in 2025. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 738 payments — averaging $99.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$47K
- Esperion Therapeutics, Inc.$16K
- Novartis$2K
- CMP Pharma, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$924
- AstraZeneca$852
- plus $6K from 30 others
What the payments were for
- Speaking & faculty fees$45,91962%
- Travel & lodging$14,59420%
- Food & beverage$13,08718%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 154 | $47,211 |
| Esperion Therapeutics, Inc. | 63 | $15,723 |
| Novartis | 115 | $1,988 |
| CMP Pharma, Inc. | 4 | $1,396 |
| E.r. Squibb & Sons, L.L.C. | 67 | $924 |
| AstraZeneca | 45 | $852 |
| Pfizer | 39 | $710 |
| Merck | 32 | $577 |
| Alnylam Pharmaceuticals Inc. | 24 | $493 |
| Philips North America LLC | 17 | $466 |
| Boehringer Ingelheim | 23 | $439 |
| Johnson & Johnson | 36 | $436 |
| Boston Scientific | 20 | $377 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $337 |
| Bayer | 15 | $241 |
| Kiniksa Pharmaceuticals, Ltd. | 13 | $229 |
| Scpharmaceuticals Inc. | 10 | $186 |
| Kiniksa Pharmaceuticals International, PLC | 7 | $139 |
| Actelion Pharmaceuticals US, Inc. | 6 | $129 |
| Abbott | 6 | $120 |
| Novo Nordisk | 4 | $110 |
| Chiesi USA, Inc. | 5 | $104 |
| Lexicon Pharmaceuticals, Inc. | 3 | $59 |
| Arbor Pharmaceuticals, Inc. | 4 | $54 |
| Edwards Lifesciences | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Atricure, Inc. | 2 | $50 |
| Cvrx, Inc. | 1 | $43 |
| Medtronic | 1 | $40 |
| Bridgebio Pharma, Inc. | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Impulse Dynamics (USA) Inc. | 1 | $22 |
| Sanofi | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Abiomed | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$73,689 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 308 | $331,466 |
| Repatha SureclickEvolocumab | 136 | $129,238 |
| EntrestoSacubitril/Valsartan | 69 | $99,525 |
| CamzyosMavacamten | 11 | $87,985 |
| JardianceEmpagliflozin | 41 | $50,330 |
| XareltoRivaroxaban | 36 | $34,341 |
| NexlizetBempedoic Acid/Ezetimibe | 27 | $16,884 |
| NexletolBempedoic Acid | 23 | $14,883 |
| Ezetimibe | 216 | $6,761 |
| Rosuvastatin Calcium | 287 | $5,179 |
| Valsartan | 131 | $3,996 |
| Carvedilol | 338 | $3,907 |
| Telmisartan | 123 | $3,714 |
| Prasugrel Hcl | 17 | $3,627 |
| Metoprolol Succinate | 238 | $3,588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $710 | $331,466308 claims |
| NovartisEntresto | $1,988 | $99,52569 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $924 | $87,98511 claims |
| Boehringer IngelheimJardiance | $439 | $50,33041 claims |
| Johnson & JohnsonXarelto | $436 | $34,34136 claims |
| Esperion Therapeutics, Inc.Nexlizet, Nexletol | $15,723 | $31,76750 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Columbia
- Sydney MorrisColumbia$11K
- Janelle HinsonColumbia$11K
- Karen DolezalColumbia$11K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.